Biotech News
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
investors.exagen.com2026-05-06 15:13 EST
CARLSBAD, Calif. , Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025 , before the market opens on Tuesday, November 4, 2025 .